For example, whole blood can be stabilized and stored with minimal gene degradation using PAXgene (Preanalytix, Hombrechtikon, Switzerland), but when using samples without CTC enrichment, 75.7% of individuals without prostate cancer test positive for AR-V7, reflecting a low specificity for the test system [13]. This evidence concerns the gene AR and prostate cancer.